venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $115M (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 65.8%

Value $75.49M Shares 4,289,304 Share Price $17.60 * Est. Cost/Share $21.15 Unrealized @ Report Date -23.8%

HRMY HARMONY BIOSCIENCES HLDGS IN 13.5%

Value $15.46M Shares 489,194 Share Price $31.60 Est. Cost/Share $36.46 Unrealized @ Report Date -11.8%

ALMS ALUMIS INC 12.1%

Value $13.86M Shares 4,619,803 Share Price $3.00 * Est. Cost/Share $9.90 Unrealized @ Report Date -52.3%

LYEL LYELL IMMUNOPHARMA INC 3.6%

Value $4.186M Shares 473,479 Share Price $8.84 * Est. Cost/Share $9.11 Unrealized @ Report Date 0.0%

ALXO ALX ONCOLOGY HLDGS INC 3.5%

Value $4.026M Shares 9,699,925 Share Price $0.42 * Est. Cost/Share $39.31 Unrealized @ Report Date -98.7%

ARTV ARTIVA BIOTHERAPEUTICS INC 1.5%

Value $1.735M Shares 1,148,975 Share Price $1.51 * Est. Cost/Share $11.59 Unrealized @ Report Date -81.9%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PHVS	PHARVARIS N V	4,289,304	$75.49M	65.8%	$17.60 *	$21.15	-23.8%	COM	N69605108
HRMY	HARMONY BIOSCIENCES HLDGS IN	489,194	$15.46M	13.5%	$31.60	$36.46	-11.8%	COM	413197104
ALMS	ALUMIS INC	4,619,803	$13.86M	12.1%	$3.00 *	$9.90	-52.3%	COM	022307102
LYEL	LYELL IMMUNOPHARMA INC	473,479	$4.186M	3.6%	$8.84 *	$9.11	0.0%	COM NEW	55083R203
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$4.026M	3.5%	$0.42 *	$39.31	-98.7%	COM	00166B105
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,148,975	$1.735M	1.5%	$1.51 *	$11.59	-81.9%	COM	04317A107